Cargando…
DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
BACKGROUND: Methylation-induced silencing of promoter CpG islands in tumor suppressor genes plays an important role in human carcinogenesis. In colorectal cancer, the CpG island methylator phenotype (CIMP) is defined as widespread and elevated levels of DNA methylation and CIMP+ tumors have distinct...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986689/ https://www.ncbi.nlm.nih.gov/pubmed/24674026 http://dx.doi.org/10.1186/1471-230X-14-55 |
_version_ | 1782311755041472512 |
---|---|
author | Loh, Marie Liem, Natalia Vaithilingam, Aparna Lim, Pei Li Sapari, Nur Sabrina Elahi, Eiram Mok, Zuan Yu Cheng, Chee Leong Yan, Benedict Pang, Brendan Salto-Tellez, Manuel Yong, Wei Peng Iacopetta, Barry Soong, Richie |
author_facet | Loh, Marie Liem, Natalia Vaithilingam, Aparna Lim, Pei Li Sapari, Nur Sabrina Elahi, Eiram Mok, Zuan Yu Cheng, Chee Leong Yan, Benedict Pang, Brendan Salto-Tellez, Manuel Yong, Wei Peng Iacopetta, Barry Soong, Richie |
author_sort | Loh, Marie |
collection | PubMed |
description | BACKGROUND: Methylation-induced silencing of promoter CpG islands in tumor suppressor genes plays an important role in human carcinogenesis. In colorectal cancer, the CpG island methylator phenotype (CIMP) is defined as widespread and elevated levels of DNA methylation and CIMP+ tumors have distinctive clinicopathological and molecular features. In contrast, the existence of a comparable CIMP subtype in gastric cancer (GC) has not been clearly established. To further investigate this issue, in the present study we performed comprehensive DNA methylation profiling of a well-characterised series of primary GC. METHODS: The methylation status of 1,421 autosomal CpG sites located within 768 cancer-related genes was investigated using the Illumina GoldenGate Methylation Panel I assay on DNA extracted from 60 gastric tumors and matched tumor-adjacent gastric tissue pairs. Methylation data was analysed using a recursively partitioned mixture model and investigated for associations with clinicopathological and molecular features including age, Helicobacter pylori status, tumor site, patient survival, microsatellite instability and BRAF and KRAS mutations. RESULTS: A total of 147 genes were differentially methylated between tumor and matched tumor-adjacent gastric tissue, with HOXA5 and hedgehog signalling being the top-ranked gene and signalling pathway, respectively. Unsupervised clustering of methylation data revealed the existence of 6 subgroups under two main clusters, referred to as L (low methylation; 28% of cases) and H (high methylation; 72%). Female patients were over-represented in the H tumor group compared to L group (36% vs 6%; P = 0.024), however no other significant differences in clinicopathological or molecular features were apparent. CpG sites that were hypermethylated in group H were more frequently located in CpG islands and marked for polycomb occupancy. CONCLUSIONS: High-throughput methylation analysis implicates genes involved in embryonic development and hedgehog signaling in gastric tumorigenesis. GC is comprised of two major methylation subtypes, with the highly methylated group showing some features consistent with a CpG island methylator phenotype. |
format | Online Article Text |
id | pubmed-3986689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39866892014-04-16 DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach Loh, Marie Liem, Natalia Vaithilingam, Aparna Lim, Pei Li Sapari, Nur Sabrina Elahi, Eiram Mok, Zuan Yu Cheng, Chee Leong Yan, Benedict Pang, Brendan Salto-Tellez, Manuel Yong, Wei Peng Iacopetta, Barry Soong, Richie BMC Gastroenterol Research Article BACKGROUND: Methylation-induced silencing of promoter CpG islands in tumor suppressor genes plays an important role in human carcinogenesis. In colorectal cancer, the CpG island methylator phenotype (CIMP) is defined as widespread and elevated levels of DNA methylation and CIMP+ tumors have distinctive clinicopathological and molecular features. In contrast, the existence of a comparable CIMP subtype in gastric cancer (GC) has not been clearly established. To further investigate this issue, in the present study we performed comprehensive DNA methylation profiling of a well-characterised series of primary GC. METHODS: The methylation status of 1,421 autosomal CpG sites located within 768 cancer-related genes was investigated using the Illumina GoldenGate Methylation Panel I assay on DNA extracted from 60 gastric tumors and matched tumor-adjacent gastric tissue pairs. Methylation data was analysed using a recursively partitioned mixture model and investigated for associations with clinicopathological and molecular features including age, Helicobacter pylori status, tumor site, patient survival, microsatellite instability and BRAF and KRAS mutations. RESULTS: A total of 147 genes were differentially methylated between tumor and matched tumor-adjacent gastric tissue, with HOXA5 and hedgehog signalling being the top-ranked gene and signalling pathway, respectively. Unsupervised clustering of methylation data revealed the existence of 6 subgroups under two main clusters, referred to as L (low methylation; 28% of cases) and H (high methylation; 72%). Female patients were over-represented in the H tumor group compared to L group (36% vs 6%; P = 0.024), however no other significant differences in clinicopathological or molecular features were apparent. CpG sites that were hypermethylated in group H were more frequently located in CpG islands and marked for polycomb occupancy. CONCLUSIONS: High-throughput methylation analysis implicates genes involved in embryonic development and hedgehog signaling in gastric tumorigenesis. GC is comprised of two major methylation subtypes, with the highly methylated group showing some features consistent with a CpG island methylator phenotype. BioMed Central 2014-03-28 /pmc/articles/PMC3986689/ /pubmed/24674026 http://dx.doi.org/10.1186/1471-230X-14-55 Text en Copyright © 2014 Loh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Loh, Marie Liem, Natalia Vaithilingam, Aparna Lim, Pei Li Sapari, Nur Sabrina Elahi, Eiram Mok, Zuan Yu Cheng, Chee Leong Yan, Benedict Pang, Brendan Salto-Tellez, Manuel Yong, Wei Peng Iacopetta, Barry Soong, Richie DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach |
title | DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach |
title_full | DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach |
title_fullStr | DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach |
title_full_unstemmed | DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach |
title_short | DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach |
title_sort | dna methylation subgroups and the cpg island methylator phenotype in gastric cancer: a comprehensive profiling approach |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986689/ https://www.ncbi.nlm.nih.gov/pubmed/24674026 http://dx.doi.org/10.1186/1471-230X-14-55 |
work_keys_str_mv | AT lohmarie dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT liemnatalia dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT vaithilingamaparna dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT limpeili dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT saparinursabrina dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT elahieiram dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT mokzuanyu dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT chengcheeleong dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT yanbenedict dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT pangbrendan dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT saltotellezmanuel dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT yongweipeng dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT iacopettabarry dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach AT soongrichie dnamethylationsubgroupsandthecpgislandmethylatorphenotypeingastriccanceracomprehensiveprofilingapproach |